The AHA and other national hospital organizations today asked congressional leaders to include in the next COVID-19 legislative package provisions to shield from unwarranted liability the health care facilities and providers treating patients during the pandemic. 

“As you are aware, a number of state leaders have either issued Executive Orders or enacted legislation to support their health care facilities and professionals,” the letter notes. “These measures are designed to shield front-line providers from the legal exposure that results from actions and decisions undertaken in responding to an unprecedented public health emergency. However, not every state has taken action, and a federal legislative approach is necessary to ensure a consistent level of protection is available for every facility and provider.”

In addition to AHA, the letter was signed by America’s Essential Hospitals, the Association of American Medical Colleges, Catholic Health Association of the United States, Children’s Hospital Association, Federation of American Hospitals, National Association for Behavioral Healthcare, Premier health care alliance and Vizient Inc.

Related News Articles

Headline
The Department of Health and Human Services Sept. 18 announced it will take new actions to help improve care for individuals with long COVID. They include a…
Headline
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…
Headline
The Centers for Disease Control and Prevention is predicting a similar combined number of peak hospitalizations from COVID-19, the flu and respiratory…
Headline
The Occupational Safety and Health Administration today announced a 60-day extension of the comment period on its proposed rule to remove the remaining…
Headline
COVID-19 infections are growing or likely growing in 45 states and not changing in five states, according to the latest data from the Centers for Disease…
Headline
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium…